Image description
Image description
Image description

A Little Bit About Us

Comprised of Chemists, Microbiologists, Engineers, Process Specialists, Quality Specialists, and Controls Specialists, our PAT team uses science, knowledge, technology, data management, and analysis as the basis for all we do.  Whether you are planning an entirely new line or facility, or you wish to retrofit existing technology, CleanTech scientists can assist you with determining the critical parameters of your process.
Our engineers can help design your facility and select the multivariate data acquisition and analysis tools to monitor and control those parameters. 
Image description

Our staff has over 240 years of combined industry experience. Our diverse consultants are hand-picked for each individual project in accordance with their expertise and experience, a crucial element to any project.

Our Consultants all have direct, hands-on industry experience. Each of our Senior Staff members has spent at least 15 years in industry, typically in management positions. We are specialists in emerging technology and regulatory trends.

We guarantee that your facility will comply with the latest regulatory norms. We make industries technically viable for next 15 years.


Today’s pharmaceutical manufacturing is more complicated than ever. We offer a unique mix of local and global experience to help you overcome current and future challenges.

The modern history of small molecule pharmaceuticals started in 1899, when Bayer was awarded the patent for Aspirin®. Since then, an industrial revolution has improved the quality of life for many people by providing access to important treatments of a wide range of diseases.Aspirin which started its career as a painkiller is now a multifacet drug.

Ayurveda and Homepathic treatments which were once considered as Eastern is now a leading pharmaceutical force. Both of these have passed their 'traditional' branding and is the developing force of the pharmaceutical industry. '

Today, many pharmaceutical companies are facing patent expiry of significant products and generic competition is becoming stronger and stronger. The pressure for cost-effective production goes hand in hand with a continued or even increased focus on product quality. The pharmaceutical industry is forced to reinvent itself – through new quality paradigms, more efficient production and more cost-effective supply chains.

The art of manufacturing traditional pharmaceuticals is becoming more multi-faceted, due to the increased diversity of the supply chain of most pharmaceutical companies. New suppliers of raw materials, potential sourcing from contract manufacturers, an increasingly international supply chain, more markets, diversity in batch sizes, different regulations, labelling or traceability requirements are just some examples.

The expiry of patents and the rearranged supply chains represent the end of the ’blockbuster’ era. Innovation-driven pharmaceutical companies are looking into increasingly specialised pharmaceuticals besides their branded generics.

We know that many of our customers see the challenge – and we offer our help in many areas. As a global company, we follow the trends and opportunities of regulations, best practice industry standards and technology through our global network. And more importantly, we offer services locally through our many offices, adapted to your local needs as well as your global challenges.

Popular Posts

Wednesday the 14th

Our new focus is on Eco-friendly design elements for everyone.

Image description

Thursday the 15th

Image description

Progress requires new ideas. These ideas are what move companies.